Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "Omicron"

125 News Found

Corbevax to be administered to children between 12-14 years
News | March 14, 2022

Corbevax to be administered to children between 12-14 years

Govt announces vaccination programme for kids and those above 60 years of age


WHO includes molnupiravir in its Covid-19 treatment guidelines
Biotech | March 03, 2022

WHO includes molnupiravir in its Covid-19 treatment guidelines

This ninth update of WHO’s guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used for patients infected with the Omicron variant


Prenetics Partners and ACON Bio launch Covid-19 antigen kits
Medical Device | February 27, 2022

Prenetics Partners and ACON Bio launch Covid-19 antigen kits

Flowflex antigen test detects Covid-19, including the Omicron variant, in just 15 minutes with 98.8% accuracy


Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine
News | February 24, 2022

Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine

100% efficacy against severe Covid-19 disease and hospitalizations


CanSinoBIO's Convidecia approved as heterologous booster in China
News | February 21, 2022

CanSinoBIO's Convidecia approved as heterologous booster in China

Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants


Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus
News | February 21, 2022

Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus

CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan


Moderna announces expansion in key Asian markets
News | February 16, 2022

Moderna announces expansion in key Asian markets

New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong


Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19
Drug Approval | February 14, 2022

Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19

Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data


Kriya Medical Technologies receives manufacturing license for KRIVIDA Novus RT-PCR Kit
Medical Device | February 14, 2022

Kriya Medical Technologies receives manufacturing license for KRIVIDA Novus RT-PCR Kit

The KRIVIDA Novus RT-PCR kit can detect the Omicron variant, its sub-lineages, and the Delta variant in 45 minutes


India’s first mRNA vaccine should be ready soon
News | February 11, 2022

India’s first mRNA vaccine should be ready soon

It is being developed by Pune-based Gennova Biopharmaceuticals